eagle-i University of Hawaii at ManoaUniversity of Hawaii at Manoa
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Temozolomide and radiation therapy with or without bevacizumab in treating patients with newly diagnosed glioblastoma

eagle-i ID

http://hawaii.eagle-i.net/i/00000130-ddd3-1595-9953-50a980000000

Resource Type

  1. Clinical trial

Properties

  1. ClinicalTrials.gov url
    http://www.clinicaltrials.gov/ct2/show/NCT00884741?term=RTOG-0825&rank=1
  2. Intervention
    Temozolide
  3. Intervention
    Radiation therapy
  4. Intervention
    Bevacizumab
  5. Resource Description
    This randomized phase III trial is studying temozolomide and radiation therapy to compare how well they work when given together with or without bevacizumab in treating patients with newly diagnosed glioblastoma. (gliosarcoma closed to accrual as of 07-13-10).
  6. Additional Name
    Phase III double-blind placebo-controlled trial of conventional concurrent chemoradiation and adjuvant temozolomide plus bevacizumab versus conventional concurrent chemoradiation and adjuvant temozolomide in patients with newly diagnosed glioblastoma
  7. Contact
    Berenberg, Jeffrey
  8. PI
    Berenberg, Jeffrey
  9. Topic
    glioblastoma multiforme
  10. Funded by
    Radiation Therapy Oncology Group
  11. Phase
    Phase 3 clinical trial
  12. Performed by
    Clinical Protocol & Data Management Shared Resource
 
RDFRDF
 
Provenance Metadata About This Resource Record
Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016